SpringWorks Therapeutics (SWTX) Short Interest Ratio & Short Volume $46.99 0.00 (0.00%) As of 07/1/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SpringWorks Therapeutics Short Interest DataSpringWorks Therapeutics (SWTX) has a short interest of 6.38 million shares, representing 9.19% of the float (the number of shares available for trading by the public). This marks a 2.24% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 2.62 million shares to cover all short positions.Current Short Interest6,380,000 sharesPrevious Short Interest6,240,000 sharesChange Vs. Previous Month+2.24%Dollar Volume Sold Short$298.46 millionShort Interest Ratio1.2 Days to CoverLast Record DateJune 15, 2025Outstanding Shares75,350,000 sharesShort Percent of Float9.19%Today's Trading Volume0 sharesAverage Trading Volume2,617,309 sharesToday's Volume Vs. Average0% Short Selling SpringWorks Therapeutics? Sign up to receive the latest short interest report for SpringWorks Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSWTX Short Interest Over TimeSWTX Days to Cover Over TimeSWTX Percentage of Float Shorted Over Time SpringWorks Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20256,380,000 shares $298.46 million +2.2%9.2%1.2 $46.78 5/31/20256,240,000 shares $291.53 million +4.7%9.1%1.3 $46.72 5/15/20255,960,000 shares $274.64 million +13.1%8.7%1.3 $46.08 4/30/20255,270,000 shares $244.00 million -33.5%N/A1.1 $46.30 4/15/20257,920,000 shares $297.71 million -4.4%11.5%2.9 $37.59 3/31/20258,280,000 shares $365.40 million +10.0%12.0%3.2 $44.13 3/15/20257,530,000 shares $385.08 million +5.9%11.0%3.3 $51.14 2/28/20257,110,000 shares $410.67 million -22.0%10.3%3.2 $57.76 2/15/20259,110,000 shares $523.19 million -36.7%13.3%4.6 $57.43 1/31/202514,400,000 shares $540 million +5.4%N/A8 $37.50 Get the Latest News and Ratings for SWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202513,660,000 shares $457.34 million +11.3%N/A10.3 $33.48 12/31/202412,270,000 shares $443.32 million +5.0%N/A10.2 $36.13 12/15/202411,690,000 shares $447.73 million -1.5%N/A10.4 $38.30 11/30/202411,870,000 shares $492.37 million -3.4%N/A10.9 $41.48 11/15/202412,290,000 shares $447.97 million +5.7%N/A11.3 $36.45 10/31/202411,630,000 shares $350.41 million -8.9%N/A13.3 $30.13 10/15/202412,770,000 shares $389.49 million +4.8%N/A13.8 $30.50 9/30/202412,180,000 shares $390.25 million -11.1%N/A13.2 $32.04 9/15/202413,700,000 shares $512.65 million +7.7%N/A15.4 $37.42 8/31/202412,720,000 shares $530.55 million -4.4%N/A15.2 $41.71 8/15/202413,300,000 shares $481.59 million +16.8%N/A16 $36.21 7/31/202411,390,000 shares $409.01 million +7.9%N/A13.9 $35.91 7/15/202410,560,000 shares $441.83 million +1.3%N/A12.9 $41.84 6/30/202410,420,000 shares $392.52 million -7.3%N/A13.2 $37.67 6/15/202411,240,000 shares $433.30 million +4.1%N/A13.9 $38.55 5/31/202410,800,000 shares $447.77 million +1.0%N/A12.8 $41.46 5/15/202410,690,000 shares $483.19 million +6.8%N/A11.5 $45.20 4/30/202410,010,000 shares $467.37 million -5.0%N/A8.8 $46.69 4/15/202410,540,000 shares $448.06 million -1.1%N/A9.5 $42.51 3/31/202410,660,000 shares $524.69 million -4.6%N/A9.3 $49.22 3/15/202411,170,000 shares $561.63 million +0.4%N/A9.3 $50.28 2/29/202411,130,000 shares $548.26 million -2.5%N/A8.5 $49.26 2/15/202411,410,000 shares $548.02 million +9.6%N/A7.6 $48.03 1/31/202410,410,000 shares $459.39 million No ChangeN/A7.7 $44.13 1/15/202410,410,000 shares $426.08 million -7.1%N/A8.3 $40.93 12/31/202311,210,000 shares $409.17 million +2.0%N/A9.2 $36.50 12/15/202310,990,000 shares $373.55 million +7.9%N/A9.8 $33.99 11/30/202310,190,000 shares $309.67 million +3.2%N/A10.2 $30.39 11/15/20239,870,000 shares $217.83 million -3.3%20.4%16.4 $22.07 10/31/202310,210,000 shares $233.81 million -1.7%21.2%17.7 $22.90A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 10/15/202310,390,000 shares $235.75 million -27.0%21.6%19.7 $22.69 9/30/202314,230,000 shares $329.00 million -2.4%29.5%27.6 $23.12 9/15/202314,580,000 shares $384.04 million +0.3%30.2%28.4 $26.34 8/31/202314,530,000 shares $409.46 million -3.7%N/A24.7 $28.18 8/15/202315,090,000 shares $439.72 million +0.1%N/A24 $29.14 7/31/202315,080,000 shares $473.21 million +1.0%N/A24 $31.38 7/15/202314,930,000 shares $427.00 million -0.1%31.5%23.1 $28.60 6/30/202314,940,000 shares $391.73 million +8.9%31.5%22.3 $26.22 6/15/202313,720,000 shares $384.98 million +11.0%28.9%19.8 $28.06 5/31/202312,360,000 shares $338.42 million +3.1%26.1%17.9 $27.38 5/15/202311,990,000 shares $368.45 million +3.7%25.3%17.1 $30.73 4/30/202311,560,000 shares $270.27 million +3.4%24.7%17.2 $23.38 4/15/202311,180,000 shares $267.54 million -4.1%23.9%16.3 $23.93 3/31/202311,660,000 shares $300.13 million -5.7%25.2%16.7 $25.74 3/15/202312,370,000 shares $391.02 million +6.5%26.8%16.8 $31.61 2/28/202311,620,000 shares $370.68 million +1.7%26.1%16.2 $31.90 2/15/202311,430,000 shares $348.27 million -6.7%25.7%16.5 $30.47 1/31/202312,250,000 shares $384.65 million -1.8%29.7%16.5 $31.40 1/15/202312,480,000 shares $362.04 million +9.1%28.0%16.5 $29.01 12/30/202211,440,000 shares $297.55 million +10.3%25.6%15.1 $26.01 12/15/202210,370,000 shares $234.05 million -10.7%23.5%13.8 $22.57 11/30/202211,610,000 shares $280.73 million -4.1%26.3%14.6 $24.18 11/15/202212,100,000 shares $331.54 million +9.5%27.4%14.5 $27.40 10/31/202211,050,000 shares $265.31 million +7.6%25.1%12 $24.01 10/15/202210,270,000 shares $258.80 million +4.4%23.3%11.4 $25.20 9/30/20229,840,000 shares $280.74 million +16.5%22.6%11 $28.53 9/15/20228,450,000 shares $257.05 million -5.1%24.5%9 $30.42 8/31/20228,900,000 shares $247.15 million -4.2%23.3%8.9 $27.77 8/15/20229,290,000 shares $283.53 million -24.2%28.8%6.7 $30.52 7/31/202212,260,000 shares $366.33 million +3.3%38.8%9.4 $29.88 7/15/202211,870,000 shares $350.64 million +3.9%37.5%9.4 $29.54 6/30/202211,430,000 shares $281.41 million +7.3%36.1%9.2 $24.62 6/15/202210,650,000 shares $223.33 million +43.2%33.6%9 $20.97 5/31/20227,440,000 shares $140.91 million +21.8%23.5%7.5 $18.94 5/15/20226,110,000 shares $239.45 million +5.2%19.2%10.8 $39.19 4/30/20225,810,000 shares $249.31 million +17.6%18.3%13.1 $42.91 4/15/20224,940,000 shares $264.64 million +15.2%15.6%11.8 $53.57 3/31/20224,290,000 shares $242.13 million +10.6%13.6%9.7 $56.44 3/15/20223,880,000 shares $206.45 million +2.7%12.3%9.3 $53.21 2/28/20223,780,000 shares $213.91 million -1.6%11.9%9.1 $56.59 2/15/20223,840,000 shares $225.75 million +11.3%12.2%9.5 $58.79 1/31/20223,450,000 shares $192.10 million +23.7%11.8%8.7 $55.68 1/15/20222,790,000 shares $174.32 million +6.1%8.9%7.3 $62.48 12/31/20212,630,000 shares $163.01 million -9.0%8.3%7.9 $61.98 12/15/20212,890,000 shares $205.51 million -2.7%9.1%8.6 $71.11 11/30/20212,970,000 shares $213.39 million -12.7%9.4%9.1 $71.85 11/15/20213,400,000 shares $236.74 million -15.2%10.7%11.1 $69.63 10/29/20214,010,000 shares $268.91 million +7.8%12.7%13.2 $67.06 10/15/20213,720,000 shares $227.37 million +13.8%11.8%12.9 $61.12 9/30/20213,270,000 shares $207.45 million +4.5%10.4%12.3 $63.44A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 9/15/20213,130,000 shares $225.77 million -4.3%9.9%12.5 $72.13 8/31/20213,270,000 shares $245.58 million +3.8%10.4%13.8 $75.10 8/13/20213,150,000 shares $237.23 million -5.1%10.0%13.3 $75.31 7/30/20213,320,000 shares $284.52 million -1.8%10.9%14.7 $85.70 7/15/20213,380,000 shares $263.67 million -2.6%9.3%15 $78.01 6/30/20213,470,000 shares $285.96 million -1.4%9.5%15.1 $82.41 6/15/20213,520,000 shares $280.47 million -7.4%9.7%14.2 $79.68 5/28/20213,800,000 shares $309.85 million +0.3%10.4%13.8 $81.54 5/14/20213,790,000 shares $258.93 million -4.1%10.4%11.5 $68.32 4/30/20213,950,000 shares $289.46 million -3.0%10.9%11.4 $73.28 4/15/20214,070,000 shares $295.89 million +8.5%11.2%11.6 $72.70 3/31/20213,750,000 shares $256.80 million +9.7%10.6%9.9 $68.48 3/15/20213,420,000 shares $268.47 million +4.0%9.7%8.8 $78.50 2/26/20213,290,000 shares $292.81 million +8.2%9.7%9.5 $89.00 2/12/20213,040,000 shares $272.96 million -2.6%9.0%9.7 $89.79 1/29/20213,120,000 shares $251.41 million -10.3%9.3%9.2 $80.58 1/15/20213,480,000 shares $259.75 million -1.1%10.3%10.2 $74.64 12/31/20203,520,000 shares $255.13 million +18.9%10.4%10.6 $72.48 12/15/20202,960,000 shares $221.64 million -5.4%8.7%8.2 $74.88 11/30/20203,130,000 shares $212.84 million +2.6%9.2%8.5 $68.00 11/15/20203,050,000 shares $205.84 million +1.7%9.0%8.8 $67.49 10/30/20203,000,000 shares $178.44 million +6.4%9.0%9.2 $59.48 10/15/20202,820,000 shares $162.60 million -10.5%9.0%9.7 $57.66 9/30/20203,150,000 shares $150.16 million +37.0%10.1%11.4 $47.67 9/15/20202,300,000 shares $99.73 million +0.9%8.2%9.4 $43.36 8/31/20202,280,000 shares $101.25 million +5.1%8.1%10.7 $44.41 8/14/20202,170,000 shares $89.06 million +3.3%7.7%10.3 $41.04 7/31/20202,100,000 shares $89.52 million +1.5%7.5%10.1 $42.63 SWTX Short Interest - Frequently Asked Questions What is SpringWorks Therapeutics' current short interest? Short interest is the volume of SpringWorks Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 6,380,000 shares of SWTX short. 9.19% of SpringWorks Therapeutics' shares are currently sold short. Learn More on SpringWorks Therapeutics' current short interest. What is a good short interest ratio for SpringWorks Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SWTX shares currently have a short interest ratio of 1.0. Learn More on SpringWorks Therapeutics's short interest ratio. Which institutional investors are shorting SpringWorks Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of SpringWorks Therapeutics: Jane Street Group LLC, Twin Securities Inc., Caption Management LLC, Eisler Capital Management Ltd., Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Maven Securities LTD, Summit Securities Group LLC, Simplex Trading LLC, and Covestor Ltd. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for SpringWorks Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.19% of SpringWorks Therapeutics' floating shares are currently sold short. Is SpringWorks Therapeutics' short interest increasing or decreasing? SpringWorks Therapeutics saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 6,380,000 shares, an increase of 2.2% from the previous total of 6,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does SpringWorks Therapeutics' short interest compare to its competitors? 9.19% of SpringWorks Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SpringWorks Therapeutics: Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S Sponsored ADR (0.28%), Dr. Reddy's Laboratories Ltd (1.34%), Moderna, Inc. (19.15%), Regencell Bioscience Holdings Limited (4.03%), Viatris Inc. (3.51%), Qiagen N.V. (2.51%), Ascendis Pharma A/S (6.16%), BridgeBio Pharma, Inc. (14.05%), Blueprint Medicines Corporation (5.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short SpringWorks Therapeutics stock? Short selling SWTX is an investing strategy that aims to generate trading profit from SpringWorks Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SpringWorks Therapeutics? A short squeeze for SpringWorks Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SWTX, which in turn drives the price of the stock up even further. How often is SpringWorks Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SWTX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Intra-Cellular Therapies Short Squeeze Genmab A/S Short Squeeze Dr. Reddy's Laboratories Short Squeeze Moderna Short Squeeze Regencell Bioscience Short Squeeze Viatris Short Squeeze Qiagen Short Squeeze Ascendis Pharma A/S Short Squeeze BridgeBio Pharma Short Squeeze Blueprint Medicines Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SWTX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SWTX Stock Alerts